Reversing a model of Parkinson’s disease with in situ converted nigral neurons-Reference-Cited by-同舟云学术

Reversing a model of Parkinson’s disease with in situ converted nigral neurons

Published:2020-06-24 Issue:7813 Volume:582 Page:550-556
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Qian Hao,Kang Xinjiang,Hu Jing,Zhang Dongyang^ORCID,Liang Zhengyu,Meng Fan,Zhang Xuan,Xue Yuanchao^ORCID,Maimon Roy,Dowdy Steven F.,Devaraj Neal K.^ORCID,Zhou Zhuan^ORCID,Mobley William C.,Cleveland Don W.^ORCID,Fu Xiang-Dong^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-020-2388-4.pdf

Reference53 articles.

1. Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Primers 3, 17013 (2017).

2. Barker, R. A., Götz, M. & Parmar, M. New approaches for brain repair—from rescue to reprogramming. Nature 557, 329–334 (2018).

3. Sonntag, K. C. et al. Pluripotent stem cell-based therapy for Parkinson’s disease: current status and future prospects. Prog. Neurobiol. 168, 1–20 (2018).

4. Cohen, D. E. & Melton, D. Turning straw into gold: directing cell fate for regenerative medicine. Nat. Rev. Genet. 12, 243–252 (2011).

5. Yu, X., Nagai, J. & Khakh, B. S. Improved tools to study astrocytes. Nat. Rev. Neurosci. 21, 121–138 (2020).

Cited by 354 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Astroglial membrane camouflaged Ptbp1 siRNA delivery hinders glutamate homeostasis via SDH/Nrf2 pathway;Biomaterials;2025-01

2. In situ chemical reprogramming of astrocytes into neurons: A new hope for the treatment of central neurodegenerative diseases?;European Journal of Pharmacology;2024-11

3. Vitexin attenuates neuropathic pain by regulating astrocyte autophagy flux and polarization via the S1P/ S1PR1-PI3K/ Akt axis;European Journal of Pharmacology;2024-10

4. DNA methylation controls stemness of astrocytes in health and ischaemia;Nature;2024-09-04

5. Protocol for transplantation of cells derived from human midbrain organoids into a Parkinson’s disease mouse model to restore motor function;STAR Protocols;2024-09